The Texas Lung Injury Institute, The University of Texas Health Science Center at Tyler, 11937 US Highway 271, Biomedical Research Building, Lab C-5, Tyler, TX 75708, USA.
Am J Respir Cell Mol Biol. 2012 Feb;46(2):196-206. doi: 10.1165/rcmb.2011-0071OC.
The low-density lipoprotein receptor-related protein 1 (LRP-1) binds and can internalize a diverse group of ligands, including members of the fibrinolytic pathway, urokinase plasminogen activator (uPA), and its receptor, uPAR. In this study, we characterized the role of LRP-1 in uPAR processing, collagen synthesis, proteolysis, and migration in pleural mesothelial cells (PMCs). When PMCs were treated with the proinflammatory cytokines TNF-α and IL-1β, LRP-1 significantly decreased at the mRNA and protein levels (70 and 90%, respectively; P < 0.05). Consequently, uPA-mediated uPAR internalization was reduced by 80% in the presence of TNF-α or IL-1β (P < 0.05). In parallel studies, LRP-1 neutralization with receptor-associated protein (RAP) significantly reduced uPA-dependent uPAR internalization and increased uPAR stability in PMCs. LRP-1-deficient cells demonstrated increased uPAR t(1/2) versus LRP-1-expressing PMCs. uPA enzymatic activity was also increased in LRP-1-deficient and neutralized cells, and RAP potentiated uPA-dependent migration in PMCs. Collagen expression in PMCs was also induced by uPA, and the effect was potentiated in RAP-treated cells. These studies indicate that TNF-α and IL-1β regulate LRP-1 in PMCs and that LRP-1 thereby contributes to a range of pathophysiologically relevant responses of these cells.
低密度脂蛋白受体相关蛋白 1(LRP-1)可结合并内化多种配体,包括纤维蛋白溶解途径成员、尿激酶纤溶酶原激活物(uPA)及其受体 uPAR。在这项研究中,我们研究了 LRP-1 在 uPAR 加工、胶原合成、蛋白水解和胸膜间皮细胞(PMCs)迁移中的作用。当 PMCs 用促炎细胞因子 TNF-α 和 IL-1β 处理时,LRP-1 在 mRNA 和蛋白质水平上均显著下降(分别为 70%和 90%;P<0.05)。因此,在 TNF-α或 IL-1β存在的情况下,uPA 介导的 uPAR 内化减少了 80%(P<0.05)。在平行研究中,用受体相关蛋白(RAP)中和 LRP-1 显著降低了 uPA 依赖性 uPAR 内化,并增加了 PMCs 中的 uPAR 稳定性。LRP-1 缺陷细胞的 uPAR t(1/2) 比 LRP-1 表达的 PMCs 增加。LRP-1 缺陷和中和细胞中的 uPA 酶活性也增加,RAP 增强了 PMCs 中 uPA 依赖性迁移。uPA 还诱导 PMCs 中胶原的表达,而在 RAP 处理的细胞中这种作用增强。这些研究表明,TNF-α 和 IL-1β 调节 PMCs 中的 LRP-1,而 LRP-1 则有助于这些细胞的一系列与病理生理相关的反应。